Pediatr. praxi. 2022;23(6):383-393 | DOI: 10.36290/ped.2022.069

Migraine in children and its treatment

MUC. Tereza Strnadová, MUDr. Petra Matalová, Ph.D.
Ústav farmakologie, LF UP a FN Olomouc

Headache is a common problem in adults, but also in children. It occurs in nearly every child. The most common type of headache is migraine, which is described as a chronic paroxysmal disease of a benign nature. Migraine is one of the primary headaches. It leads to deterioration in the quality of life in childhood and it can also cause increased stress for parents and negatively affect the family life. The article summarizes the epidemiology, classification, specifics and therapeutic procedures in migraine.

Keywords: migraine, childhood, treatment, prophylaxis.

Accepted: November 16, 2022; Published: November 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strnadová T, Matalová P. Migraine in children and its treatment. Pediatr. praxi. 2022;23(6):383-393. doi: 10.36290/ped.2022.069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Želinská K. Ošetřovatelská péče u dětí s bolestmi hlavy [dissertation]. České Budějovice: Jihočeská univerzita v Českých Budějovicích; 2016.
    2. Ambler Z, Bednařík J, Růžička E, et al. Klinická neurologie: část speciální 1. Praha: Triton; 2010.
    3. Muchová M, Ošlejšková H. Migréna v dětském věku. Neurol. praxi. 2007;3:163-167.
    4. Nežádal T, Marková J, Bártková A, et al. Mezinárodní klasifikace bolestí hlavy (ICHD-3) - oficiální český překlad. Česk Slov Neurol N. 2020;83(2):145-152. Go to original source...
    5. Muchová M. Migréna v dětství a adolescenci - epidemiologie, specifika, terapie. Remedia. 2009;19:355-361.
    6. Sýkora P. Bolesti hlavy u detí. Pediatria pre prax. 2007;1:39-41.
    7. Neklanová M. Bolesti hlavy u školních dětí. Pediatr. praxi. 2007;8(4):233-236.
    8. Novotná I. Bolesti hlavy, migréna, léčba a profylaxe. Neurol. praxi. 2019;20(4):302-306. Go to original source...
    9. Marková J. Migréna. Cesk Slov Neurol N. 2009;72/105(3):207-215.
    10. Ambler Z, Bednařík J, Růžička E, et al. Klinická neurologie: část obecná. Praha: Triton; 2010.
    11. Bose P, Goadsby PJ. The migraine postdrome. Curr Opin Neurol. 2016;29(3):299-301. Go to original source... Go to PubMed...
    12. Pejčochová J. Klinická zkušenost s užitím kresby v diagnostice bolesti hlavy dětí. Neurol. praxi. 2012;13(3):166-170.
    13. Lewis DW. Migraine headaches in the adolescent. Adolescent Med. 2002;13(3):413-432.
    14. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders. 3rd edition. Cephalalgia 2018; 38(1):1-211. Go to original source...
    15. Jen JC. Familial Hemiplegic Migraine. 2001 Jul 17 [Updated 2021 Apr 29]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1388/.
    16. Mastík J, Migréna - Nová mezinárodní klasifikace a moderní léčebné postupy. Neurol. praxi. 2004;2:79-83.
    17. Klečka L. Diferenciální diagnostika migrény. Neurol. praxi 2019;20(6):444-450.
    18. Kalousová J. Bolest u dětí: Hodnocení a některé způsoby léčby. Pediatr. praxi. 2008;(1):7-11.
    19. Dušičková T, Toumová K, Tóthová V. Porovnání nástrojů sloužících k hodnocení bolesti v předškolním a mladším školním věku v České republice a zahraničí. Pediatr. praxi. 2019;20(4):261-264. Go to original source...
    20. Horák O, Ošlejšková H. Idiopatické "benigní" fokální epilepsie v dětství. Neurol. praxi. 2014;15(3):141-145.
    21. Havránek J, Schejbalová M, Dedek V, et al. Purulentní meningitidy v dětském věku. Pediatr. praxi. 2009;10(1):20-24.
    22. Liu J, Wang G, Dan Y, et al. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine. J Headache Pain. 2022;23(1):68. Go to original source... Go to PubMed...
    23. Muchová M. PedMIDAS - dotazník k hodnocení dětské migrény. Neurol. praxi. 2009;10(2):117-119.
    24. Richer LP, Laycock K, Millar K, et al. Treatment of children with migraine in emergency departments: National Practice Variation Study. Pediatrics. 2010;126-150. Go to original source... Go to PubMed...
    25. Damen L, Bruijn JK, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005;116:295-302. Go to original source... Go to PubMed...
    26. Kabbouche MA, Linder SL. Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatr Ann. 2005;34:466-471. Go to original source... Go to PubMed...
    27. Tura P, Erdur B, Aydin B, et al. Slow infusion metoclopramide does not affect the improvement rate of nausea while reducing akathisia and sedation incidence. Emerg Med J. 2012;29:108-112. Go to original source... Go to PubMed...
    28. Bachur RG, Monuteaux MC, Neuman MI. A comparison of acute treatment regimens for migraine in the emergency department. Pediatrics. 2015;135:232-238. Go to original source... Go to PubMed...
    29. Winner P, Pearlman EM, Linder SL, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005; 45:1304. Go to original source... Go to PubMed...
    30. Miller GS. Efficacy and safety of Levetiracetam in pediatric migraine. Headache. 2004;44:238. Go to original source... Go to PubMed...
    31. Ryzí M. Farmakoterapie u primárních bolestí hlavy. Pedia­tr. praxi. 2019;20(2):88-92. Go to original source...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.